Novo Nordisk
NVO
NVO
932 hedge funds and large institutions have $16.3B invested in Novo Nordisk in 2022 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 323 increasing their positions, 312 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 901 → 932 (+31)
1.4% more ownership
Funds ownership: 15.56% → 16.96% (+1.4%)
4% more repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 312
Holders
932
Holding in Top 10
39
Calls
$140M
Puts
$124M
Top Buyers
| 1 | +$554M | |
| 2 | +$407M | |
| 3 | +$310M | |
| 4 |
Millennium Management
New York
|
+$122M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$111M |
Top Sellers
| 1 | -$177M | |
| 2 | -$170M | |
| 3 | -$94.8M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$65.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$62M |